HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between periventricular leukomalacia and retinopathy of prematurity.

AbstractPURPOSE:
To investigate the correlation between periventricular leukomalacia (PVL) and retinopathy of prematurity (ROP), which are complications of perinatal and postnatal hypoxic-ischemic insults in premature infants.
METHODS:
In this retrospective case series study, from 1996 to 2008, after excluding cases with follow-up of less than 3 months, we reviewed medical charts of babies who had gestational age (GA) less than 30 weeks or birthweight (BW) less than 2000 g. A total of 195 patients were diagnosed with ROP and/or PVL and were enrolled in this analysis. We investigated the correlation between ROP and PVL with Pearson chi-square test and evaluated BW, GA, and Apgar scores at 1 minute and 5 minutes after birth as risk factors by independent t test.
RESULTS:
There were no significant differences in the prevalence of PVL between patients who received ROP treatment and those who did not receive ROP treatment. The BW was significantly lower in patients with PVL than in patients without PVL. Gestational age, BW, and Apgar scores significantly differed between patients who did and did not receive retinal treatment for ROP.
CONCLUSIONS:
Periventricular leukomalacia did not increase the severity of ROP or requirement of ROP treatment. Birthweight, GA, and Apgar scores were the principal factors that determined the necessity of ROP treatment.
AuthorsHsiu-Mei Huang, Sue-Ann Lin, Ying-Chao Chang, Hsi-Kung Kuo
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) Vol. 22 Issue 6 Pg. 980-4 ( 2012) ISSN: 1724-6016 [Electronic] United States
PMID22388777 (Publication Type: Journal Article)
Topics
  • Apgar Score
  • Birth Weight
  • Female
  • Gestational Age
  • Humans
  • Infant
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infant, Premature
  • Leukomalacia, Periventricular (diagnosis, physiopathology, therapy)
  • Male
  • Prevalence
  • Retinopathy of Prematurity (diagnosis, physiopathology, therapy)
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: